MedTrace Logo

Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy

NCT04253860 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-04

No results posted yet for this study

Summary

Double-blind, randomized, placebo-controlled, clinical trial. Patients with diabetic neuropathy will be randomly assigned to treatment with either TENS or TENS sham three times a week during 90 days. Clinical determinations are: pain, levesls of TNF-alpha, IL-6 and RPC-us

Conditions

  • Diabetic Neuropathy Peripheral

Interventions

DEVICE

Transcutaneous electrical neurostimulation

Sessions of 30 minutes of TENS will be applied three times a week during 90 days

Sponsors & Collaborators

  • University of Guadalajara

    collaborator OTHER

  • Diabetes sin Complicaciones S.A de C.V, Mexico

    collaborator UNKNOWN

  • Centro Universitario de Tonalá

    lead OTHER

Principal Investigators

  • Arieh R Mercado Sesma, PhD · Salud Enfermedad como proceso individual, CUTonalá, Universidad de Guadalajara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-09-01
Completion
2021-07-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04253860 on ClinicalTrials.gov